» Articles » PMID: 34194816

Exploiting the Neuroprotective Effects of α-klotho to Tackle Ageing- and Neurodegeneration-related Cognitive Dysfunction

Overview
Journal Neuronal Signal
Date 2021 Jul 1
PMID 34194816
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cognitive dysfunction is a key symptom of ageing and neurodegenerative disorders, such as Alzheimer's disease (AD). Strategies to enhance cognition would impact the quality of life for a significant proportion of the ageing population. The α-klotho protein may protect against cognitive decline through multiple mechanisms: such as promoting optimal synaptic function via activation of N-methyl-d-aspartate (NMDA) receptor signalling; stimulating the antioxidant defence system; reducing inflammation; promoting autophagy and enhancing clearance of amyloid-β. However, the molecular and cellular pathways by which α-klotho mediates these neuroprotective functions have yet to be fully elucidated. Key questions remain unanswered: which form of α-klotho (transmembrane, soluble or secreted) mediates its cognitive enhancing properties; what is the neuronal receptor for α-klotho and which signalling pathways are activated by α-klotho in the brain to enhance cognition; how does peripherally administered α-klotho mediate neuroprotection; and what is the molecular basis for the beneficial effect of the VS variant of α-klotho? In this review, we summarise the recent research on neuronal α-klotho and discuss how the neuroprotective properties of α-klotho could be exploited to tackle age- and neurodegeneration-associated cognitive dysfunction.

Citing Articles

The relationship between serum alpha-klotho levels and urinary incontinence in middle-aged and older females: insights from NHANES.

Tang X, Song Y, Liang H, He W, Chen Z, Yang L Sci Rep. 2024; 14(1):28667.

PMID: 39562625 PMC: 11577013. DOI: 10.1038/s41598-024-80231-6.


Association between the duration of smoking cessation and α-Klotho levels in the US middle-aged and elderly population.

Du R, Tang X, Yang C, Shi J, Lai Y, Ding S Heliyon. 2024; 10(19):e38298.

PMID: 39398068 PMC: 11467537. DOI: 10.1016/j.heliyon.2024.e38298.


Exploring endocrine FGFs - structures, functions and biomedical applications.

Phan P, Ternier G, Edirisinghe O, Kumar T Int J Biochem Mol Biol. 2024; 15(4):68-99.

PMID: 39309613 PMC: 11411148. DOI: 10.62347/PALK2137.


Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging.

Prudhomme G, Wang Q Cells. 2024; 13(17.

PMID: 39272986 PMC: 11394293. DOI: 10.3390/cells13171413.


Association of elevated cerebrospinal fluid levels of the longevity protein α-Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.

Zimmermann M, Fandrich M, Jakobi M, Roben B, Wurster I, Lerche S Eur J Neurol. 2024; 31(10):e16388.

PMID: 38946703 PMC: 11414814. DOI: 10.1111/ene.16388.


References
1.
Erickson C, Schultz S, Oh J, Darst B, Ma Y, Norton D . heterozygosity attenuates -related amyloid burden in preclinical AD. Neurology. 2019; 92(16):e1878-e1889. PMC: 6550504. DOI: 10.1212/WNL.0000000000007323. View

2.
Nagai T, Yamada K, Kim H, Kim Y, Noda Y, Imura A . Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J. 2002; 17(1):50-2. DOI: 10.1096/fj.02-0448fje. View

3.
Zhao Y, Zeng C, Li X, Yang T, Kuang X, Du J . Klotho overexpression improves amyloid-β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease. Aging Cell. 2020; :e13239. PMC: 7576297. DOI: 10.1111/acel.13239. View

4.
Fukui K, Omoi N, Hayasaka T, Shinnkai T, Suzuki S, Abe K . Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann N Y Acad Sci. 2002; 959:275-84. DOI: 10.1111/j.1749-6632.2002.tb02099.x. View

5.
Abraham C, Mullen P, Tucker-Zhou T, Chen C, Zeldich E . Klotho Is a Neuroprotective and Cognition-Enhancing Protein. Vitam Horm. 2016; 101:215-38. DOI: 10.1016/bs.vh.2016.02.004. View